Dallah Healthcare board declares 10% cash dividend for H2 2021
The board of directors of Dallah Healthcare Co. declared today, Dec. 14, the distribution of cash dividend at SAR 1 per share, or 10% of the capital, for the second half of 2021, according to a bourse filing.
|
Dividend Details (H2 2021) |
|
|
Current Capital |
SAR 900 mln |
|
Number of shares |
90 mln |
|
Dividend |
SAR 90 mln |
|
Percentage of capital |
10% (SAR 1 per share) |
|
Record date |
Dec. 16, 2021 (Shareholders registered with Edaa by the end of second trading day following the due date). |
|
Payment date |
Dec. 30, 2021 |
|
Dividend Details (FY2021) |
|
|
Dividend |
SAR 135 mln |
|
Percentage of capital |
15% (SAR 1.5 per share) |
Dividend History (SAR/share) Corporate Actions
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 15/12/2021 | 30/12/2021 | 16/12/2021 | 90.00 | 1.00 | |
| 22/09/2021 | 30/09/2021 | 14/10/2021 | 45.00 | 0.50 | |
| 23/03/2021 | 28/03/2021 | 11/04/2021 | 22.50 | 0.25 | |
| 15/12/2020 | 24/12/2020 | 28/12/2020 | 45.00 | 0.50 | |
| 27/02/2020 | 22/03/2020 | 05/04/2020 | 52.50 | 0.58 | |
| 12/11/2019 | 28/11/2019 | 05/12/2019 | 37.50 | 0.42 | |
| 13/12/2018 | 20/12/2018 | 06/01/2019 | 88.50 | 0.98 | |
| 13/12/2017 | 22/05/2018 | 11/06/2018 | 147.50 | 1.64 | |
| 23/02/2017 | 26/04/2017 | 08/05/2017 | 118.00 | 1.31 | |
| 21/01/2016 | 02/05/2016 | 31/05/2016 | 88.50 | 0.98 |
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any
Dividend History
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | 3.25 | 36.72 | 8.85 % |
| Last 5 Financial years | 5.87 | 62.47 | 9.40 % |
| Last 10 Financial years | 10.26 | 30.16 | 34.04 % |
Based on the beginning of the period (January 1 of the base year)
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Most Read
- Avalon Pharma renews SAR 50M credit facilities with Alinma Bank
- Al Rashid Industrial to distribute 6% cash dividend for H1 2026
- Which stocks, REITs go ex-dividend today
- Alkhaleej Training targets SAR 550M topline in 2026
- Sector pressures not reflective of fundamental weakness; demand expected to improve in Q3: Budget Saudi CEO
Valuation Data (Latest Share Price)
| P/E (TTM) | 23.21 |
| Recurring P/E (TTM) | 23.32 |
| P/BV | 2.49 |
| Dividend Yield | 1.59 % |
| Market Cap. (M) | 10,279.40 |
| Return on Average Assets | 4.83 % |
| Return on Average Equity | 10.72 % |
Call Request
Comments Analysis: